Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, announced new Phase 3b topline Week 16 results from Cohort A of the VISIBLE trial, the first prospective, large-scale, randomized-controlled ...

Credit: Arcutis. The approval was supported by data from 2 randomized, double-blind, vehicle-controlled trials that included 736 patients aged 12 years and older with mild to severe plaque psoriasis ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Tremfya showed greater persistence in bio-naïve and ...

A recent Phase 3 clinical trial demonstrated that a steroid-free topical foam, roflumilast (Zoryve), significantly improved the signs and symptoms of psoriasis on both the scalp and body. The foam ...

Roflumilast foam is a steroid-free, once-daily treatment for plaque psoriasis, effective on the scalp and body. Clinical trials showed significant improvements in psoriasis clearance and itch relief, ...

Once-daily roflumilast foam, 0.3% (Zoryve) significantly improved scalp and body symptoms of plaque psoriasis in a phase III trial. Improvements in scalp itch were also greater for patients randomized ...

Reader's DigestHome Remedies for Eczema and Psoriasis ReliefSave money on expensive skin care treatments and try these homemade remedies first. Plaque psoriasis is a skin disease that causes raised ...

Psoriasis treatments have been a staple of TV advertising for nearly 50 years. That’s because the skin disease is relatively widespread throughout the United States. Roughly 80 to 90 percent of ...

Katlein Franca, MD, is a dermatologist and clinical associate professor of Dermatology & Cutaneous Surgery and Psychiatry & Behavioral Sciences at the University of Miami. Scalp psoriasis is a ...